Search results
Results from the 24/7 Vacations Content Network
Learn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
Spikevax 2024-2025 Formula made by Moderna is an mRNA COVID-19 vaccine that may help your body develop immunity to SARS-CoV-2, the virus that causes COVID-19. Spikevax is an FDA-approved vaccine for adults and adolescents aged 12 years and older.
FDA approved (SPIKEVAX ®) and granted emergency use authorization (Moderna COVID-19 Vaccine 2024-2025 Formula) on August 22, 2024.
Patients can visit SPIKEVAX.comHealthcare Professionals can visit SPIKEVAXPRO.com. How can we help you? Online: Moderna's Adverse Event Intake Portal or U.S. HHS's Vaccine Adverse Event Reporting System. Email:WeCare@modernatx.com Call:1-866-MODERNA (1-866-663-3762) Monday - Friday 8:00 AM to 8:00 PM ET (closed holidays)
The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and...
Moderna COVID-19 Vaccine (Original monovalent), and Moderna COVID-19 Vaccine, Bivalent. There is a very small chance that SPIKEVAX could cause a severe allergic reaction. A severe allergic...
SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Updated June 24, 2022 Recommended for People 18 Years and Older and Children Ages 6 months to 5 Years Primary Series: • 18 years and older: 2 doses of Moderna in the primary series, given 4–8 weeks apart. People who are moderately or severely immunocompromised (have a weakened immune system) should get a 3rd dose at least 4 weeks after ...
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as...